Answers are grounded in this paper and cite their sources.
Background/Objectives: This study aimed to reappraise the practice of treating admission-day blood values as a fixed baseline in sudden sensorineural hearing loss (SSNHL). Blood markers were grouped into clinical axes A (acute cellular stress), B (reserve/protein), and C (acute-phase response) and tested for associations with onset, baseline pure-tone average (PTA), and recovery at timings E0, Eb, and Δ. Methods: First SSNHL episodes were identified in a single-center OMOP CDM (n = 5311; 2002–2025). Markers were classified into three clinical axes (A/B/C), and sampling timing was separated into E0, Eb, and Δ. Prespecified hypotheses were H1 (onset OR for Eb 36-month NLR, TP, and Glb), H2 (E0 albumin–PTA), and H3 (E0 CAR–PTA). Onset used 1:4 age–sex matched odds ratios; PTA used linear regression; recovery used logistic regression. Exploratory analyses were controlled with Benjamini–Hochberg FDR. Recovery sensitivity definitions and indication-stratified rematching were applied. Results: Under H1, onset ORs were NLR 1.05 (1.03–1.07), TP 0.81 (0.73–0.90), and Glb 0.83 (0.73–0.95). Under H2, E0 albumin–PTA β was −12.94 (−17.49 to −8.40; q < 0.001). Under H3, E0 CAR–PTA β was 6.88 (1.61–12.15; q = 0.039). E0 NLR was unrelated to PTA. Recovery remained null after definition diversification and FDR. After indication-stratified rematching, the NLR onset OR and E0 albumin/CAR–PTA signals were retained. Conclusions: SSNHL blood markers should be reported by clinical axis (A/B/C) and sampling timing (E0/Eb/Δ). Onset and baseline-severity signals persist after indication adjustment, whereas evidence for recovery prediction remains weak.
No takes yet. Share an insight, caveat, or question.
Yoon et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: